A comprehensive two-day symposium on Hypertrophic Cardiomyopathy (HCM), bringing together leading experts to explore the evolving landscape of HCM diagnosis, risk stratification, and evidence-based management. Through expert-led sessions, live echocardiography cases, interactive clinical discussions, and engaging debates, the symposium will address key challenges in identifying HCM, distinguishing mimics, assessing sudden cardiac death risk, optimizing medical therapy, and navigating advanced treatment options, including myosin inhibitors and septal reduction therapies. Designed to bridge clinical evidence with real-world practice, the program aims to equip cardiologists with practical insights and greater confidence in managing patients across the HCM spectrum.